Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Hanauer Jds"'
Autor:
Alexander Muik, Hanauer Jds, Thorsten Friedel, Johanna Reul, Sebastian Newrzela, Pfeiffer A, Christian J. Buchholz, Irene C. Schneider, M. L. Hansmann, Dina Kleinlützum, Benjamin Rengstl
Publikováno v:
Oncotarget
Classical Hodgkin lymphoma (cHL) is a hematopoietic malignancy with a characteristic cellular composition. The tumor mass is made up of infiltrated lymphocytes and other cells of hematologic origin but only very few neoplastic cells that are mainly i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e131c71b5a02d80dc43ac5ccdda91e
https://doi.org/10.18632/oncotarget.24191
https://doi.org/10.18632/oncotarget.24191
Autor:
Agarwal S; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany., Hanauer JDS; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany., Frank AM; Division for Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany; Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany., Riechert V; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany., Thalheimer FB; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany., Buchholz CJ; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany; Division for Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany; Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany. Electronic address: christian.buchholz@pei.de.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2020 Aug 05; Vol. 28 (8), pp. 1783-1794. Date of Electronic Publication: 2020 May 16.
Autor:
Krug, Adrien1,2 (AUTHOR), Saidane, Aymen1,2 (AUTHOR), Martinello, Chiara1 (AUTHOR), Fusil, Floriane3 (AUTHOR), Michels, Alexander4 (AUTHOR), Buchholz, Christian J.4,5 (AUTHOR), Ricci, Jean-Ehrland1,2 (AUTHOR), Verhoeyen, Els1,2,3 (AUTHOR) els.verhoeyen@unice.fr
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 9/14/2024, Vol. 43 Issue 1, p1-18. 18p.
Autor:
Hanauer JDS; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Rengstl B; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany.; Current address: BioNTech Cell and Gene Therapies GmbH, 55131 Mainz, Germany., Kleinlützum D; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Reul J; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Pfeiffer A; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Friedel T; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Schneider IC; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Newrzela S; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany.; Current address: BioNTech Cell and Gene Therapies GmbH, 55131 Mainz, Germany., Hansmann ML; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany., Buchholz CJ; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Muik A; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.; Current address: BioNTech RNA Pharmaceuticals GmbH, 55131 Mainz, Germany.
Publikováno v:
Oncotarget [Oncotarget] 2018 Jan 12; Vol. 9 (16), pp. 12971-12981. Date of Electronic Publication: 2018 Jan 12 (Print Publication: 2018).
Autor:
Kleinlützum D; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Hanauer JDS; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Muik A; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Hanschmann KM; Biostatistics, Paul-Ehrlich-Institut, Langen, Germany., Kays SK; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Ayala-Breton C; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Peng KW; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Mühlebach MD; Product Testing of Immunological Medicinal Products for Veterinary Use, Paul-Ehrlich-Institut, Langen, Germany., Abel T; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany., Buchholz CJ; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2017 Jun 26; Vol. 7, pp. 127. Date of Electronic Publication: 2017 Jun 26 (Print Publication: 2017).
Publikováno v:
Cancer Communications; Sep2024, Vol. 44 Issue 9, p1071-1097, 27p
Publikováno v:
Molecular Oncology; Aug2024, Vol. 18 Issue 8, p1821-1848, 28p
Publikováno v:
Annals of Hematology; Aug2024, Vol. 103 Issue 8, p2569-2589, 21p
Autor:
Haikun Lin, Chentao Li, Wanying Zhang, Boxiang Wu, Yanan Wang, Shimin Wang, Dongrui Wang, Xia Li, He Huang
Publikováno v:
International Journal of Biological Sciences; 2024, Vol. 20 Issue 9, p2833-2859, 27p
Publikováno v:
Frontiers in Immunology; 2024, p1-12, 12p